Tumor biology - Herceptin acts as an anti-angiogenic cocktail

被引：501

作者：

Izumi, Y ^{[1
]}

Xu, L ^{[1
]}

di Tomaso, E ^{[1
]}

Fukumura, D ^{[1
]}

Jain, RK ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA

来源：

NATURE | 2002年 / 416卷 / 6878期

关键词：

D O I：

10.1038/416279b

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：279 / 280

页数：2

共 12 条

[1] c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems
Allgayer, H
Babic, R
Gruetzner, KU
Tarabichi, A
Schildberg, FW
Heiss, MM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2201 - 2209
[2] Thrombospondins as matricellular modulators of cell function
Bornstein, P
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (08) : 929 - 934
[3] Angiogenic heterogeneity: Regulation of neoplastic angiogenesis by the organ microenvironment
Fidler, IJ
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14): : 1040 - 1041
[4] Tumor induction of VEGF promoter activity in stromal cells
Fukumura, D
Xavier, R
Sugiura, T
Chen, Y
Park, EC
Lu, NF
Selig, M
Nielsen, G
Taksir, T
Jain, RK
Seed, B
[J]. CELL, 1998, 94 (06) : 715 - 725
[5] Vessels of death or life
Jain, RK
Carmeliet, PF
[J]. SCIENTIFIC AMERICAN, 2001, 285 (06) : 38 - 45
[6] Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, RK
[J]. NATURE MEDICINE, 2001, 7 (09) : 987 - 989
[7] JAIN RK, IN PRESS NATURE REV
[8] 'Accidental' anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples
Kerbel, RS
Viloria-Petit, A
Klement, G
Rak, J
[J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (10) : 1248 - 1257
[9] Post-transcriptional control regulates transforming growth factor alpha in the human carcinoma KB cell line
Nicolini, G
Miloso, M
Moroni, MC
Beguinot, L
Scotto, L
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) : 30290 - 30296
[10] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Slamon, DJ
Leyland-Jones, B
Shak, S
Fuchs, H
Paton, V
Bajamonde, A
Fleming, T
Eiermann, W
Wolter, J
Pegram, M
Baselga, J
Norton, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) : 783 - 792

← 1 2 →